1-3 of 3
Ana García Feria
Close
Sort by
Journal Articles

Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma Included in the Compassionate Use or the Expanded Access Program. Experience with a Spanish Cohort

Javier De La Rubia, Rafael Alonso, Maria Esther Clavero Sanchez, Elham Askari, Alfonso García de Coca, Ana Maldonado, Margarita Fernandez De La Mata, Fernando Escalante, Ana Garcia-Feria, Rafael Rios, Venancio Conesa, Maria Aranzazu Bermudez, Beatriz Merchan, Alberto Velasco, María Jesús Blanchard, Antonia Sampol, Eukene Gainza González, Pedro M Hernandez, Veronica Gonzalez-Calle, Adrian Alegre
Journal: Blood
Blood (2022) 140 (Supplement 1): 4315–4317.
https://doi.org/10.1182/blood-2022-158538
Published: 2022
Journal Articles

Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set

Clinical Trials & Observations
Ajai Chari, Mehmet Kemal Samur, Joaquin Martinez-Lopez, Gordon Cook, Noa Biran, Kwee Yong, Vania Hungria, Monika Engelhardt, Francesca Gay, Ana García Feria, Stefania Oliva, Rimke Oostvogels, Alessandro Gozzetti, Cara Rosenbaum, Shaji Kumar, Edward A. Stadtmauer, Hermann Einsele, Meral Beksac, Katja Weisel, Kenneth C. Anderson, María-Victoria Mateos, Philippe Moreau, Jesus San-Miguel, Nikhil C. Munshi, Hervé Avet-Loiseau
Journal: Blood
Blood (2020) 136 (26): 3033–3040.
https://doi.org/10.1182/blood.2020008150
Published: 2020
Includes: Supplemental data
Journal Articles

Activity and Safety of Daratumumab Monotheray in Patients with Relapsed and Refractory Multiple Myeloma Requiring Dialysis: Preliminary Results of Spanish, Retrospective, Multicenter Trial

Maria José Cejalvo, Mario Legarda, Eugenia Abella, Elena Cabezudo, Cristina Encinas, Ana García-Feria, Belén Iñigo, Jesús Marín, Paz Ribas, M. Ángeles Ruíz, Javier de la Rubia
Journal: Blood
Blood (2017) 130 (Supplement 1): 1866.
https://doi.org/10.1182/blood.V130.Suppl_1.1866.1866
Published: 2017